PETS — Stock Film
STOCK FILMSCENE 1/11PETS · $1.76
Stock Expert AI presents
PETS
PetMed Express, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
PetMed Express, Inc. A quick introduction.

On the stock market since 1999, it operates in the world of consumer spending. It has 189 employees. Now — the numbers.

on the stock market since 1999
189 employees
$42.3M market value
Revenue last year:
$0
The loss that same year:
$0
For every $1 it earns, the company spends $1.3.

The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.

THE SALES TREND
Sales have been shrinking.

An average decline of 10% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.

$273.4M
2022
$256.6M
2023
$274.1M
2024
$227M
2025
$179M
2026
In the vault right now:
$0
DEBT: $535K
At this pace, that money lasts less than a year.

Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
6
very weak

Clearly below the class average.

FINANCIAL STRENGTH
24
very weak

Clearly below the class average.

VALUATION
10
very weak

Clearly below the class average.

GROWTH
3
very weak

Clearly below the class average.

PRICE MOMENTUM
12
very weak

Clearly below the class average.

WORTH WATCHING

Growth: Sales growth trails the sector average.

Business Quality: Profit power and business quality trail similar companies in the sector.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Few are betting against it10/10
WEAK SPOTS
The stock has lost its spark0/10
Growth has stalled2/10
Costs eat into the margin4/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
A long and steep decline.

An investor who bought at the very peak is down 95% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.

1
THE BRIGHT SIDE · 1/3
Executives are buying their own stock

Over the last 12 months, company executives reported 13 buys and 1 sell. Management buying with its own money is usually read as a good sign.

2
THE BRIGHT SIDE · 2/3
Analysts’ target sits above today’s price

The average analyst price target is $11.00525% above today’s price.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $1.20 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/2
Small sales, big loss

A loss of $57.3M against $179.0M in annual sales. And on top of that, sales fell from the year before.

2
THE RISKS · 2/2
The cash has a countdown

At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.

FINALE · THE GRADE
F
0 / 100 · MoonshotScore

On our five-subject report card, PETS sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: PETS is a small company that closed last year at a loss. The road back to profit runs through spending discipline.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

Analysts’ average target sits above today’s price, yet the valuation grade (10/100) says the stock isn’t cheap.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film